Epigenetic and metabolic reprogramming alterations are two important features of tumors,
and their reversible, spatial, and temporal regulation is a distinctive hallmark of …

In light of a global rise in the number of patients with type 2 diabetes mellitus (T2DM) and
obesity, non-alcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction …

Hepatocellular carcinoma (HCC) typically develops as a consequence of liver cirrhosis, but
HCC epidemiology has evolved drastically in recent years. Metabolic dysfunction …

Simple Summary Liver cancer is one of the most frequently occurring cancer types and one
of the leading causes of cancer-related mortality globally. Despite of its constantly growing …

Aim Metabolic reprogramming has recently attracted extensive attention for understanding
cancer development. We aimed to demonstrate a genomic and transcriptomic landscape of …

The incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is
continuously rising, evolving into a global health challenge. Concurrently, cases of …

Hepatocellular carcinoma (HCC) is a common complication of chronic liver diseases and
remains a relevant cause of cancer-related mortality worldwide. The global prevalence of …

Hepatocarcinogenesis is frequently accompanied by substantial metabolic reprogramming
to maximize the growth and proliferation of cancer cells. In this study, we carried out a …

Hepatocellular carcinoma (HCC) is the primary form of liver cancer. It causes∼ 800 000
deaths per year, which is expected to increase due to increasing rates of obesity and …

Hepatology Publish Ahead of Print DOI:10.1097/HEP.0000000000000962 Page 1
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for …